A Study to Determine the Best Intra-Arterial Drug Treatments for Restoring the Arterial Lumen Following Cerebral Vasospasm

Overview

About this study

The purpose of this study is to determine the best intra-arterial drug treatment regimen for arterial lumen restoration following cerebral vasospasm after an aneurysmal subarachnoid hemorrhage.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria

  • Adult patient, age 18-80 years old
  • Has a ruptured aneurysm(s) 
  • Experienced cerebral vasospasm post operatively within 3-21 days

 

Exclusion Criteria

  • Inability to obtain consent from patient or patients kin 
  • Pregnant women 
  • < 18 years of age or > 80 years of age
  • Hunt Hess Grade 5 subarachnoid hemorrhage

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Giuseppe Lanzino, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available
.
CLS-20205735

Mayo Clinic Footer